Objective. To investigate disease activity around and during pregnancy and pregnancy
outcome in women with systemic lupus erythematosus (SLE) considering antiphospholipid …

Background: Medication use during pregnancy and lactation can be unavoidable, but
knowledge on safety for the fetus or breastfed infant is limited among patients and …

Objectives This systematic review assessed which variables are associated with or are
predictors for work participation outcomes in patients with systematic lupus erythematosus …

Objective: To relate anticoagulant use to pregnancy complications in women with systemic
lupus erythematosus (SLE) and primary antiphospholipid syndrome (APS). Methods: All …

Objectives Pre-pregnancy counselling in women with systemic lupus erythematosus (SLE) is
important in order to improve knowledge on the risks of pregnancy and to optimize …

Objective Preterm birth (PTB) is one of the most frequent complications of pregnancies in
women with systemic lupus erythematosus (SLE). The high indicated PTB proportion due to …

Abstract Background The Rheumatoid Arthritis Impact of Disease (RAID) score was
developed as a European League Against Rheumatism initiative to obtain a patient reported …

Objective: To identify predictors of sick leave and improved worker productivity in patients
with early rheumatoid arthritis (RA) treated for 52 weeks with intensive combination …

Objective To evaluate if COmbinatie therapie Bij Reumatoïde Artritis (COBRA)-light therapy
is cost-effective in treating patients with early rheumatoid arthritis (RA) compared with …

Belimumab is a human immunoglobulin G1 (IgG1)-lambda monoclonal antibody that inhibits
the B-cell survival factor BLyS. It is used as an add-on therapy in patients with active …